R ED BLOOD CELL sludging, or aggregation, has been demonstrated to accompany prolonged extracorporeal circulation, and has been implicated as a serious cause of morbidity, and occasionally even of death, following such perfusions.1 This red blood cell aggregation is characterized by slow blood flow in small vessels, clumping of red blood cells with plugging of capillaries and venules, the appearance of hyperchromatic cells, plasima skimming, and the absence of vasoconstriction. Low molecular weight dextran (LmDx) has been shown to delay the onset of, prevent, or markedly diminiish aggregation under these and other eireumstanees. ' The largest forces mutually attracting red blood cells include chemical bonding, ion pair anid triplet formation, anld surface or interfacial tension. Those The distribution of lesions in 37 patients undergoing heart operations in which the pump-oxygenator system was primed with blood and low molecular weight dextran, usually in the ratio of 2: 1, is indicated in fig. 2) . The mean change in charge in these patients was from 1.14 to 1.10 x 10-8 coulombs/cell. This contrasts Time (hrs) Figure 1 Red blood cell charge plotted against the duration of extracorporeal circulation, which separated the samples drawn at the beginning and end of bypass.
In this series, in which low molecular weight dextran was used to prime the pump-oxygenator system, all but one of the postbypass samples demonstrated an increase in red blood cell electronega,tivity.
sharply with the mean change in charge in the first group of-patients, in which low molecular weight dextran was included in the perfusing medium, where the mean electrical charge at the end of perfusion was 1.46 x 10-coulombs/cell, in conjtrast with a mnean control charge of 1.23 x 10-8 coulombs/cell.
Discussion
The results of these studies confirm the results of earlier studies performed both in vitro and in the experimental animal laboratory.5 " In these, it has been slhowin that pumping and oxygenating whole blood in an in vitro system does not appear to affect red blood cell charge. This is also true when an animal is added to the circuit. Such studies are comparable to the clinical studies reported here, in which dextrose in water was used as the priming solution. Similar results were obtained in the animal laboratory when whole blood alonie was used as a priming vehiele.
However, in in vitro stuidies, the addition of low molecular weight dextrani to whole blood results in a progressive stepwise inerease in electronegative charge. This inierease has been confirmned in experimental animal studies involving both partial and total body perfusion in which LjmDx is used to prime the svstem. The results reported here from patients perfused with low molecular weight dextran as a part of the priming volume of the pumpoxygenator system confirm the previously reported results from the experimental animal laboratory. While electric charge of the blood cells is not the only force involved in the aggregation process, and does not appear to be altered by extracorporeal circulation alone, the protective action of low molecular weight dextran appears to inelude an increase in red blood cellular electronegativity, consistent with an increase in the total forces of repulsion betweeni cells. In experimnental studies, this increase in red blood cell electronegativity is accoinpanied by a decrease in the red bloocd cell aggregation normally seeni durinig prolonged extracorporeal circulation. While red blood cell aggregation during extracorporeal circulation is niot niormally associated with changes in red blood cell charge, the effect of dextran appears to include its abilitv to counter an increase in the forces of attraction with an increase in the total forces of repulsion between cells. This appears to be of considerable value in improving perfusion in small l)lood vessels and, therefore, also of vital orgoans and tissues. 
